Conviction
$ Value
$897K
Shares
8,890
Price
$101
Filed
Mar 12
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ % of holdings >= 20% (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
MALAFRONTE MICHAEL W
Title
—
CIK
0001209162
Roles
Transaction Details
Transaction Date
2026-03-11
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
25,395
Footnotes
This transaction was executed in multiple trades at prices ranging from $99.51 to $102.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | The reported securities are held by an irrevocable trust of which the reporting person serves as a trustee. | This transaction was executed in multiple trades at prices ranging from $100.58 to $101.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Filing Info
MALAFRONTE MICHAEL W's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-11 | CVSA | ▲ | $897K |
| 2026-03-10 | CVSA | ▲ | $1.2M |
| 2026-03-10 | CVSA | ▲ | $1.5M ★ |
| 2026-03-03 | CVSA | ▲ | $118K |
| 2025-11-13 | ATGE | F | $51K |
| 2025-11-12 | ATGE | A | $140K |
| 2025-11-04 | ATGE | ▲ | $92K |
Other Insiders at CVSA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MALAFRONTE MICHAEL W | $2.9M | — | 2026-03-10 |
|
Liles Scott
President, Medical and Vet
|
— | — | 2026-04-15 |